SYDNEY GRIFFIE: Open Payments
NPI 1134702343 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,574 in 122 payments from 38 companies in 2025. Trend: 2023 $1,572 · 2024 $2,332 · 2025 $2,574
Food & beverage: $2,475Education: $99
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $281 |
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| ABBVIE INC. | 8 | $191 |
| Daiichi Sankyo Inc. | 10 | $185 |
| Janssen Biotech, Inc. | 8 | $168 |
| Incyte Corporation | 6 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $129 |
| SEAGEN INC. | 1 | $99 |
| Celgene Corporation | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
Products named: KEYTRUDA, TAGRISSO, Enhertu, VENCLEXTA, LIBTAYO, KISQALI, ZYNYZ, JAKAFI.
Industry payments across KY — which companies pay providers there.
